We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Centro Hospitalario Especializado, Ville-Evrard, sector 15, Unidad de Psiquiatría de Enlace, 2, avenue Jean Jaurès, 93330 Neuilly-sur-Marne, Francia
Addonizio, G, Susman, VL, Roth, SD. Neurleptic malignant syndrome: review and analysis of 115 cases. Biol Psychiatry1987; 22: 1004–20.Google Scholar
Caroff, SN, Mann, SC. Neuroleptic malignant syndrome. Med Clin North Am1993; 77: 185–202.CrossRefGoogle ScholarPubMed
Feibel, JH, Schiffer, RB. Sympathoadrenomedullary hyperactivity in the neuroleptic malignant syndrome: a case report. Am J Psychiatry1981; 138: 1115–16.Google ScholarPubMed
Greenblatt, DJ, Gross, PL, Harris, J, Shader, RI, Ciraulo, DA. Fatal hyperthermia following haloperidol therapy of sedative-hypnotic withdrawal. J Clin Psychiatry1978; 39: 673–5.Google ScholarPubMed
Kish, SJ, Kleinert, R, Minauf, M, Gilbert, J, Walter, GF, Slimovitch, C, Maurer, E, Rezvani, Y, Myers, R, Hornykiewicz, O. Brain neurotransmitter changes in three patients who had a fatal hyperthermia syndrome. Am J Psychiatry1990; 147: 1358–63.Google ScholarPubMed
Lew, T, Tollefson, G. Chloropromazine-induced neuroleptic malignant syndrome and its response to diazepam. Biol Psychiatry1983; 18: 1441–6.Google ScholarPubMed
Zorumski, CF, Isenberg, KE. Insights into the structure and function of GABA-benzodiazepine receptors: ion channels and psychiatry. Am J Psychiatry1991; 148: 162–73.Google ScholarPubMed